Skip to main content
GLAS
NYSE Life Sciences

Q3 Revenue Jumps 21% Sequentially but Margin Compresses as Cannabis Pricing Slumps

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.27
Mkt Cap
$246.99M
52W Low
$3.1
52W High
$13.93
52W Position info
5.5% above low
Off High info
77% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

GLAS is trading near its 52-week low of $3.1 (5.5% above the low) on elevated volume (2.1× avg).

Summary

Glass House pre-announced Q3 revenue of $56.8M, up 21% from Q2's $47.0M and more than double the $26.2M a year ago, on record biomass output of roughly 317,000 pounds. The problem is price: average selling price fell to $150 per pound from $211 in Q2, and gross margin dropped to 26% from 34%, leaving gross profit roughly flat at $14.9M. Operating cash flow was negative $0.4M, a step back from Q2's positive $0.2M. Management says it turned off the ATM after raising $18M in the quarter at an average $8.11 per share plus $10M from warrants, and ended with $39.7M in cash, up $17.6M sequentially. The company reaffirmed FY2026 production guidance of approximately 1 million pounds and its $95 per pound long-term cost target, and expects Q4 cost of production in line with Q3's $110 per pound. The board also lost director John "Jay" Nichols Jr., who resigned; no reason was given. The quarter shows volume growth masking a deteriorating California pricing environment, and the cash-flow-positive goal now rests on the $39M balance and the $95/lb cost target. This follows the September auditor change to BDO and the CFO retirement announced in late September, adding to a run of management and governance changes.

Updated with an SEC 6-K filing · What changed

Updates

  1. · SEC 6-K — Glass House reaffirmed FY2026 production guidance of approximately 1 million pounds and its $95 per pound long-term cost target, expecting Q4 cost of production in line with Q3's $110 per pound.

At the time of this announcement, GLAS was trading at $3.27 on NYSE in the Life Sciences sector, with a market capitalization of approximately $247M. The 52-week trading range was $3.10 to $13.93. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

GLAS - Latest Insights

GLAS
Oct 19, 2026, 1:58 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.34
Real-time Price: $2.33 info
Change: -$0.0100 (-0.43%) info
Market Cap: $190.469M info
GLAS
Sep 11, 2026, 4:35 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $7.93
Real-time Price: $2.33 info
Change: -$5.60 (-71%) info
Market Cap: $190.469M info
GLAS
Aug 14, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.41
Real-time Price: $2.33 info
Change: -$7.08 (-75%) info
Market Cap: $190.469M info
GLAS
Aug 13, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.45
Real-time Price: $2.33 info
Change: -$7.12 (-75%) info
Market Cap: $190.469M info
GLAS
Jul 07, 2026, 9:40 AM EDT
Source: BayStreet
Importance Score:
7
Price at Filing: $11.60
Real-time Price: $2.33 info
Change: -$9.27 (-80%) info
Market Cap: $190.469M info